Emmaus life sciences, inc. (MYND)
Income statement / Yearly
Sep'18Sep'17Sep'16Sep'15Sep'14Sep'13Sep'12Sep'11Sep'10
Total revenues

1,315

128

-

-

-

-

-

-

-

COST OF GOODS SOLD

827

53

5

4

73

-

-

-

-

GROSS PROFIT

488

75

-

-

-

-

-

-

-

Clinical services

-

-

-

-

-

-

-

-

502

Total revenues

-

-

85

100

135

130

-

-

638

Neurometric Services

-

-

-

-

-

-

115

111

136

OPERATING EXPENSES
Cost of neurometric services revenue

-

-

-

-

-

142

132

147

135

Research

231

123

53

92

116

167

264

482

738

Product development

1,146

1,237

740

691

1,338

1,119

589

442

381

Selling

1,617

1,226

522

347

390

347

997

1,132

870

General and administrative

7,737

4,590

2,530

1,613

2,034

2,554

2,938

3,197

5,017

Total operating expenses

10,733

7,178

3,851

2,749

3,951

4,331

4,920

5,402

7,143

LOSS FROM OPERATIONS

-10,244

-7,103

-3,766

-2,649

-3,816

-4,200

-4,805

-5,291

-6,505

OTHER INCOME (EXPENSE)
Offering costs

-

-

-

-

-

-

784

437

0

Other non-operating income

-

-

-

-

-

-

-

458

0

(Loss) gain on derivative liabilities

-

-

-34

162

26

-97

6,950

6,826

0

Finance fees

-

-

-20

-

-

-

-

-

-

Finance fees

-

-

-

0

-1

-

-

-

-

Other income

-

-

306

-

44

-

-

-

-

Interest expense, net

-86

-6

-2,721

-257

-11

-1,288

-4,123

-7,567

-360

Loss on debt extinguishment

-

-

572

-630

1,105

556

0

-

-

Legal settlement expense

-

-

-275

-

-

-

-

-

-

Gain on extinguishment of debt

-

-

-

-

-

-

-

-1,968

-1,094

Financing fees

-

-

-

-

-

62

151

348

213

Offering costs

-

-

-

-

-

2

-

-

-

Notes conversion expense

-

-

-

-

-

5,792

0

-

-

Other miscellaneous income - write backs

-

-

-

-

-

0

-

-

-

Total other income (expense)

-86

-6

-2,172

-724

1,161

-6,686

1,891

-3,035

-1,668

INCOME (LOSS) BEFORE INCOME TAXES

-10,331

-7,110

-5,938

-3,374

-2,654

-10,887

-2,914

-8,327

-8,173

INCOME TAXES

1

2

2

5

5

0

1

1

0

NET INCOME (LOSS) INCLUDING NONCONTROLLING INTEREST

-10,333

-7,112

-

-

-

-

-

-

-

LOSS FROM CONTINUING OPERATIONS

-

-

-

-

-2,660

-10,888

-2,916

-8,328

-

Loss from discontinued operations

-

-

-

-

-2

-19

-490

-538

-

NET INCOME (LOSS) ATTRIBUTABLE TO THE COMPANY

-9,598

-7,112

-5,940

-3,379

-2,662

-10,907

-3,406

-8,866

-8,174

COMPONENTS OF OTHER COMPREHENSIVE INCOME (LOSS)
Net loss attributable to noncontrolling interest

-734

0

-

-

-

-

-

-

-

INCOME (LOSS) BEFORE OTHER COMPRESHENSIVE INCOME

-

-

-

-

-

-

-

-8,328

-

Other comprehensive income (loss)

-

-

-

-

-

-

-

0

-

From continuing operations (in dollars per share)

-

-

-

-6.64

-0.03

-0.14

-

-

-

From discontinued operations (in dollars per share)

-

-

-

-

0.00

0.00

-

-

-

Combined Net Loss (in dollars per share)

-

-

-

-

-0.03

-

-

-

-

From continuing operations (in dollars per share)

-

-

-

-

-

-

-1.55

-4.45

-

From discontinued operations (in dollars per share)

-

-

-

-

-

-

-0.26

-0.29

-

NET INCOME (LOSS) PER COMMON SHARE - BASIC

-

-

-

-

-

-

-1.81

-4.74

-0.16

From continuing operations (in dollars per share)

-

-

-

-

-

-

-1.55

-4.45

-

From discontinued operations (in dollars per share)

-

-

-

-

-

-

-0.26

-0.29

-

NET INCOME (LOSS) PER COMMON SHARE - DILUTIVE

-

-

-

-

-

-

-1.81

-4.74

-0.16

BASIC AND DILUTED LOSS PER SHARE:

-1.86

-2.52

-9.26

-

-

-0.14

-

-

-

Basic and Diluted (in shares)

5,199

2,817

641

509

99,326

75,800

-

-

-

WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING

-

-

-

-

-

-

1,887

1,869

52,277

Diluted (in shares)

-

-

-

-

-

-

1,887

1,869

52,277